are compounded glp 1 legal 🚨 FDA Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these FDA is moving to restrict

They can help dissolve ingredients to stable bases or help evenly distribute ingredients throughout the product

If you need to cancel one of these orders, please contact us

The company would compete against: Novo Nordisk: Semaglutide products facing generic competition in 2026 Eli Lilly: Tirzepatide medications with recent price reductions Generic manufacturers: Nine companies pursuing semaglutide biosimilars Other innovators: Companies developing next-generation GLP-1 therapies Market Timeline The timeline for Pfizer's long-acting GLP-1 drug remains unclear, as clinical development and regulatory review could take several years

While better side effect management and pricing are separate issues, reducing injection frequency directly targets the adherence problem

They want to make sure you keep making progress